* LifeMD Inc LFMD.OQ reported a quarterly adjusted loss
of 23
cents per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 10 cents per share.
* Revenue rose 18% to $35.95 million from a year ago;
analysts
expected $35.17 million.
* LifeMD Inc's reported EPS for the quarter was a loss of 23
cents.
* The mean earnings estimate of analysts had risen by
about 26.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* LifeMD Inc shares had fallen by 13.8% this quarter and
gained 93.3% so far this year.
* The company reported a quarterly loss of $7.51 million.
* Wall Street's median 12-month price target for LifeMD Inc
is
$7.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 9 at 09:47 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.10 -0.23 Missed
Mar. 31 2023 -0.16 -0.15 Beat
Dec. 31 2022 -0.18 -0.40 Missed
Sep. 30 2022 -0.28 -0.26 Beat